[Federal Register Volume 75, Number 55 (Tuesday, March 23, 2010)]
[Notices]
[Page 13769]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-6189]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Natural Experiments and Effectiveness Studies To 
Identify the Best Policy and System Level Practices To Prevent Diabetes 
and Its Complications, Funding Opportunity Announcement (FOA) DP 10-
002, Initial Review

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 10 a.m.-5 p.m., May 26, 2010 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of ``Natural Experiments and 
Effectiveness Studies to Identify the Best Policy and System Level 
Practices to Prevent Diabetes and Its Complications, RFA DP 10-
002.''
    Contact Person for More Information: Donald Blackman, PhD., 
Scientific Review Officer, National Center for Chronic Disease 
Prevention and Health Promotion, Office of the Director, Extramural 
Research Program Office, 4770 Buford Highway, NE., Mailstop K-92, 
Atlanta, GA 30341, Telephone: (770) 488-3023, E-mail: [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 14, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-6189 Filed 3-22-10; 8:45 am]
BILLING CODE 4163-18-P